Tandem Autologous Hematopoietic Cell Transplantation for Patients With Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.798
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Autologous Hematopoietic Stem Cell Transplantation for Plasmablastic Lymphoma: The European Society for Blood and Marrow Transplantation Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma

Investigational New Drugs
OncologyPharmacology
2011English

Autologous Peripheral Blood Hematopoietic Cell Transplantation in Dogs With T-Cell Lymphoma

Journal of Veterinary Internal Medicine
MedicineVeterinary
2014English

Treatment Pathways and Resource Use Associated With Recurrent Hodgkin Lymphoma After Autologous Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2017English

Reduced-Intensity Hematopoietic Cell Transplantation for Patients With Primary Myelofibrosis: A Cohort Analysis From the Center for International Blood and Marrow Transplant Research

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma

Oncology Letters
Cancer ResearchOncology
2015English

Phase I Study of Tandem High-Dose Chemotherapy With Autologous Peripheral Blood Stem Cell Rescue for Children With Recurrent Brain Tumors: A Pediatric Blood and Marrow Transplant Consortium Study

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2010English

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy